Aerovate Therapeutics Inc...

2.44
0.01 (0.41%)
At close: Mar 03, 2025, 12:43 PM

Aerovate Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 23.49M 22.4M 54.2M 4.57M 3.51M
Short-Term Investments 98.95M 106.82M 113.18M n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 2.28M 2.56M 302K n/a n/a
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 1.79M 2.28M 6.96M 103K n/a
Total Current Assets 124.23M 131.5M 174.33M 4.68M 3.51M
Property-Plant & Equipment 902K 1.25M 728K 39K n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 3.19M 3.81M 1.03M 39K n/a
Total Assets 127.42M 135.3M 175.36M 4.71M 3.51M
Account Payables 2.4M 2.58M 1.21M 612K 542K
Deferred Revenue n/a n/a 1.01M n/a n/a
Short-Term Debt 420K 770K 384K n/a n/a
Other Current Liabilities 14.82M 4.44M 958K 1.16M 115K
Total Current Liabilities 17.64M 7.78M 2.55M 1.77M 657K
Long-Term Debt 255K 705K 382K n/a 2.5M
Other Long-Term Liabilities 70K 71K 13K n/a 4M
Total Long-Term Liabilities 325K 776K 395K 16.29M 6.5M
Total Liabilities 17.96M 8.56M 2.94M 18.06M 7.16M
Total Debt 675K 1.09M 574K n/a 2.5M
Common Stock 3K 2K 2K n/a n/a
Retained Earnings -163.42M -87.9M -36.39M -13.41M -3.64M
Comprehensive Income 237K -466K -59K n/a n/a
Shareholders Equity 109.46M 126.74M 172.42M -13.34M -3.64M
Total Investments 98.95M 106.82M 113.18M n/a n/a